NCT04094649 - Acute Study of Effect of Ultrasound Vagus Nerve Stimulation on Glycemia | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 1, 2019

Primary Completion Date

July 31, 2022

Study Completion Date

July 31, 2022

Conditions

Diabetes Mellitus, Type 2

Interventions

DEVICE

Ultrasound Vagus Nerve Stimulation (DECIMA)

This is a single-site, double-blind, randomized, prospective, sham-controlled, crossover early feasibility study to determine whether ultrasound Vagus Nerve Stimulation (uVNS) inhibits postprandial hyperglycemia in humans.

Trial Locations (1)

85258

Cognitive Clinical Trials, LLC, Scottsdale